Beyond catalysis, enzymes in pharmaceuticals are molecular architects, meticulously constructing complex drug compounds with unparalleled specificity, often mirroring nature’s own intricate synthesis pathways. They’re enabling the creation of previously unattainable drug targets, unlocking new frontiers in personalized medicine with their precise, bio-friendly methodologies. Enzymes in pharmaceuticals are the silent revolution, driving the development of targeted therapies by enabling the precise modification of drug molecules, leading to increased efficacy and reduced side effects.